Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	structural constituent of skin epidermis	KRT6A KRT6B KRT79 KRT75 KRT6C	2.41e-05	43	161	5	GO:0030280
GeneOntologyMolecularFunction	recombination hotspot binding	PRDM7 PRDM9	6.46e-05	2	161	2	GO:0010844
GeneOntologyBiologicalProcess	intermediate filament cytoskeleton organization	KRT6A KRT6B KRT79 NDEL1 KRT75 KRT6C PRPH	1.32e-05	99	162	7	GO:0045104
GeneOntologyBiologicalProcess	intermediate filament-based process	KRT6A KRT6B KRT79 NDEL1 KRT75 KRT6C PRPH	1.40e-05	100	162	7	GO:0045103
GeneOntologyCellularComponent	AP-2 adaptor complex	STON1 AP2A1 AP2A2	1.59e-04	14	163	3	GO:0030122
GeneOntologyCellularComponent	clathrin coat of endocytic vesicle	STON1 AP2A1 AP2A2	1.98e-04	15	163	3	GO:0030128
Domain	Keratin_2_head	KRT6A KRT6B KRT79 KRT75 KRT6C	1.47e-06	24	157	5	IPR032444
Domain	Keratin_2_head	KRT6A KRT6B KRT79 KRT75 KRT6C	1.47e-06	24	157	5	PF16208
Domain	Keratin_II	KRT6A KRT6B KRT79 KRT75 KRT6C	2.25e-06	26	157	5	IPR003054
Domain	Intermediate_filament_CS	KRT6A KRT6B KRT79 KRT75 KRT6C PRPH	1.47e-05	63	157	6	IPR018039
Domain	Filament	KRT6A KRT6B KRT79 KRT75 KRT6C PRPH	2.93e-05	71	157	6	SM01391
Domain	IF	KRT6A KRT6B KRT79 KRT75 KRT6C PRPH	3.17e-05	72	157	6	PS00226
Domain	Filament	KRT6A KRT6B KRT79 KRT75 KRT6C PRPH	3.43e-05	73	157	6	PF00038
Domain	IF	KRT6A KRT6B KRT79 KRT75 KRT6C PRPH	4.31e-05	76	157	6	IPR001664
Domain	-	AP2A1 AP2A2	7.02e-05	2	157	2	2.60.40.1030
Domain	Clathrin_a-adaptin_app_Ig-like	AP2A1 AP2A2	7.02e-05	2	157	2	IPR013038
Domain	AP2_complex_asu	AP2A1 AP2A2	7.02e-05	2	157	2	IPR017104
Domain	Clathrin_a-adaptin_app_sub_C	AP2A1 AP2A2	7.02e-05	2	157	2	IPR003164
Domain	Alpha_adaptin_C	AP2A1 AP2A2	7.02e-05	2	157	2	PF02296
Domain	Rhs_assc_core	TENM4 TENM3	2.09e-04	3	157	2	IPR022385
Domain	-	LRP1B TENM4 TENM3 LRP6	3.14e-04	39	157	4	2.120.10.30
Domain	Tox-GHH_dom	TENM4 TENM3	4.17e-04	4	157	2	IPR028916
Domain	Tox-GHH	TENM4 TENM3	4.17e-04	4	157	2	PF15636
Domain	Clathrin_a/coatomer_app_sub_C	AP2A1 AP2A2	4.17e-04	4	157	2	IPR015873
Domain	Ten_N	TENM4 TENM3	4.17e-04	4	157	2	IPR009471
Domain	Ten_N	TENM4 TENM3	4.17e-04	4	157	2	PF06484
Domain	TENEURIN_N	TENM4 TENM3	4.17e-04	4	157	2	PS51361
Domain	-	AP2A1 AP2A2	4.17e-04	4	157	2	3.30.310.30
Domain	RUN	SGSM2 DENND5A RUBCN	4.33e-04	18	157	3	SM00593
Domain	RUN	SGSM2 DENND5A RUBCN	5.11e-04	19	157	3	PS50826
Domain	RUN	SGSM2 DENND5A RUBCN	5.11e-04	19	157	3	PF02759
Domain	Run_dom	SGSM2 DENND5A RUBCN	5.11e-04	19	157	3	IPR004012
Domain	6-blade_b-propeller_TolB-like	LRP1B TENM4 TENM3 LRP6	5.96e-04	46	157	4	IPR011042
Domain	YD	TENM4 TENM3	6.91e-04	5	157	2	IPR006530
Domain	YIPPEE	YPEL3 YPEL4	6.91e-04	5	157	2	PS51792
Domain	EPTP	TSPEAR LGI1	1.03e-03	6	157	2	PF03736
Domain	EPTP	TSPEAR LGI1	1.03e-03	6	157	2	IPR005492
Domain	EAR	TSPEAR LGI1	1.43e-03	7	157	2	IPR009039
Domain	EAR	TSPEAR LGI1	1.43e-03	7	157	2	PS50912
Domain	Yippee/Mis18/Cereblon	YPEL3 YPEL4	1.90e-03	8	157	2	IPR004910
Domain	Yippee-Mis18	YPEL3 YPEL4	1.90e-03	8	157	2	PF03226
Domain	PI3K_C2	PIK3C2A PIK3C3	1.90e-03	8	157	2	SM00142
Domain	PI3K_C2_dom	PIK3C2A PIK3C3	1.90e-03	8	157	2	IPR002420
Domain	Coatomer/calthrin_app_sub_C	AP2A1 AP2A2	1.90e-03	8	157	2	IPR009028
Domain	SSXRD	PRDM7 PRDM9	1.90e-03	8	157	2	PF09514
Domain	SSXRD_motif	PRDM7 PRDM9	1.90e-03	8	157	2	IPR019041
Domain	PI3K_C2	PIK3C2A PIK3C3	1.90e-03	8	157	2	PF00792
Domain	PI3K_C2	PIK3C2A PIK3C3	1.90e-03	8	157	2	PS51547
Domain	PI3Ka	PIK3C2A PIK3C3	2.43e-03	9	157	2	PF00613
Domain	Alpha_adaptinC2	AP2A1 AP2A2	2.43e-03	9	157	2	PF02883
Domain	PI3Ka	PIK3C2A PIK3C3	2.43e-03	9	157	2	SM00145
Domain	Clathrin_a/b/g-adaptin_app_Ig	AP2A1 AP2A2	2.43e-03	9	157	2	IPR008152
Domain	Alpha_adaptinC2	AP2A1 AP2A2	2.43e-03	9	157	2	SM00809
Domain	Ptc/Disp	PTCHD1 DISP3	2.43e-03	9	157	2	IPR003392
Domain	Patched	PTCHD1 DISP3	2.43e-03	9	157	2	PF02460
Domain	-	PIK3C2A PIK3C3	2.43e-03	9	157	2	1.25.40.70
Domain	TRYPSIN_DOM	PRSS54 PRSS2 C1RL C1R TMPRSS7	2.88e-03	115	157	5	PS50240
Domain	JmjN	KDM4C KDM4A	3.02e-03	10	157	2	SM00545
Domain	JmjN	KDM4C KDM4A	3.02e-03	10	157	2	PF02375
Domain	PI_Kinase	PIK3C2A PIK3C3	3.02e-03	10	157	2	IPR015433
Domain	PInositide-3_kin_accessory_dom	PIK3C2A PIK3C3	3.02e-03	10	157	2	IPR001263
Domain	JMJN	KDM4C KDM4A	3.02e-03	10	157	2	PS51183
Domain	PIK_HELICAL	PIK3C2A PIK3C3	3.02e-03	10	157	2	PS51545
Domain	JmjN	KDM4C KDM4A	3.02e-03	10	157	2	IPR003349
Domain	Tryp_SPc	PRSS54 PRSS2 C1RL C1R TMPRSS7	3.10e-03	117	157	5	SM00020
Domain	Trypsin_dom	PRSS54 PRSS2 C1RL C1R TMPRSS7	3.58e-03	121	157	5	IPR001254
Domain	Trypsin	PRSS54 PRSS2 C1RL C1R TMPRSS7	3.58e-03	121	157	5	PF00089
Domain	KRAB_RELATED	PRDM7 PRDM9	3.67e-03	11	157	2	PS50806
Domain	Peptidase_S1_PA	PRSS54 PRSS2 C1RL C1R TMPRSS7	3.84e-03	123	157	5	IPR009003
Domain	Coatomer/clathrin_app_Ig-like	AP2A1 AP2A2	4.38e-03	12	157	2	IPR013041
Domain	LDLR_class-A_CS	LRP1B LRP6 TMPRSS7	4.58e-03	40	157	3	IPR023415
Domain	SSD	PTCHD1 DISP3	5.15e-03	13	157	2	IPR000731
Domain	SSD	PTCHD1 DISP3	5.15e-03	13	157	2	PS50156
Domain	Krueppel-associated_box-rel	PRDM7 PRDM9	5.15e-03	13	157	2	IPR003655
Domain	NHL	TENM4 TENM3	5.15e-03	13	157	2	PS51125
Domain	uDENN	SBF2 DENND5A	5.98e-03	14	157	2	SM00800
Domain	Ldl_recept_b	LRP1B LRP6	5.98e-03	14	157	2	PF00058
Domain	LDLRB	LRP1B LRP6	5.98e-03	14	157	2	PS51120
Domain	Ldl_recept_a	LRP1B LRP6 TMPRSS7	6.39e-03	45	157	3	PF00057
Domain	-	LRP1B LRP6 TMPRSS7	6.79e-03	46	157	3	4.10.400.10
Domain	Clathrin/coatomer_adapt-like_N	AP2A1 AP2A2	6.86e-03	15	157	2	IPR002553
Domain	uDENN	SBF2 DENND5A	6.86e-03	15	157	2	PF03456
Domain	PI3/4_kinase_CS	PIK3C2A PIK3C3	6.86e-03	15	157	2	IPR018936
Domain	LY	LRP1B LRP6	6.86e-03	15	157	2	SM00135
Domain	Adaptin_N	AP2A1 AP2A2	6.86e-03	15	157	2	PF01602
Domain	LDLR_classB_rpt	LRP1B LRP6	6.86e-03	15	157	2	IPR000033
Domain	TRYPSIN_SER	PRSS2 C1RL C1R TMPRSS7	7.02e-03	90	157	4	IPR033116
Domain	Znf_PHD	ASXL1 KDM4C BPTF KDM4A	7.29e-03	91	157	4	IPR001965
Domain	LDLRA_1	LRP1B LRP6 TMPRSS7	7.64e-03	48	157	3	PS01209
Domain	GRAM	TBC1D9 SBF2	7.80e-03	16	157	2	SM00568
Domain	DENN	SBF2 DENND5A	7.80e-03	16	157	2	SM00799
Domain	-	PIK3C2A PIK3C3	7.80e-03	16	157	2	1.10.1070.11
Domain	DENN	SBF2 DENND5A	7.80e-03	16	157	2	PF02141
Domain	dDENN	SBF2 DENND5A	7.80e-03	16	157	2	PF03455
Domain	PI3Kc	PIK3C2A PIK3C3	7.80e-03	16	157	2	SM00146
Domain	UDENN	SBF2 DENND5A	7.80e-03	16	157	2	PS50946
Domain	DDENN	SBF2 DENND5A	7.80e-03	16	157	2	PS50947
Domain	dDENN	SBF2 DENND5A	7.80e-03	16	157	2	SM00801
Domain	dDENN_dom	SBF2 DENND5A	7.80e-03	16	157	2	IPR005112
Domain	uDENN_dom	SBF2 DENND5A	7.80e-03	16	157	2	IPR005113
Domain	DENN	SBF2 DENND5A	7.80e-03	16	157	2	PS50211
Domain	DENN_dom	SBF2 DENND5A	7.80e-03	16	157	2	IPR001194
Domain	CUB	C1RL C1R TMPRSS7	8.09e-03	49	157	3	PF00431
Domain	LDrepeatLR_classA_rpt	LRP1B LRP6 TMPRSS7	8.09e-03	49	157	3	IPR002172
Domain	LDLa	LRP1B LRP6 TMPRSS7	8.09e-03	49	157	3	SM00192
Domain	LDLRA_2	LRP1B LRP6 TMPRSS7	8.09e-03	49	157	3	PS50068
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	KRT6A KRT6B RCN1 DNAJC18 NEB KRT79 OR5AR1 TFAM KHSRP BPTF LATS1 LATS2 KRT75 AP2A1 HOOK1 AP2A2 KRT6C SACS SAP30BP DKC1 TMPRSS7 MED13 FBXO15 PRPH	9.30e-08	1442	165	24	35575683
Pubmed	Human chromosome 21 gene expression atlas in the mouse.	ICOSLG TSPEAR NCAM1 GRIK1 SCAF4 IFNGR2 PAXBP1 KCNE1 PRMT2	9.37e-08	163	165	9	12466854
Pubmed	Genetic variants in pachyonychia congenita-associated keratins increase susceptibility to tooth decay.	KRT6A KRT6B KRT6C	1.05e-07	3	165	3	29357356
Pubmed	Mice expressing a mutant Krt75 (K6hf) allele develop hair and nail defects resembling pachyonychia congenita.	KRT6A KRT6B KRT75	1.05e-07	3	165	3	17851587
Pubmed	Keratin expression provides novel insight into the morphogenesis and function of the companion layer in hair follicles.	KRT6A KRT6B KRT75	1.05e-07	3	165	3	17170733
Pubmed	Cloning and characterization of multiple human genes and cDNAs encoding highly related type II keratin 6 isoforms.	KRT6A KRT6B KRT6C	1.05e-07	3	165	3	7543104
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	PRSS2 KLHL28 PPWD1 LRP1B ITK KHSRP KLHL3 OVGP1 LATS1 LATS2 AP2A1 AP2A2 PRMT2 SSH2 MMP3 TAF1L	4.53e-07	730	165	16	34857952
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KDM4C ATG14 USP37 TUBGCP5 TBC1D9 SCAF4 AP2A2 SACS SBF2 WDR35 DISP3 SSH2 ZNF606	7.50e-07	493	165	13	15368895
Pubmed	Pachyonychia Congenita	KRT6A KRT6B KRT6C	1.04e-06	5	165	3	20301457
Pubmed	The Effect of and Mechanism Underlying Autophagy in Hepatocellular Carcinoma Induced by CH12, a Monoclonal Antibody Directed Against Epidermal Growth Factor Receptor Variant III.	ATG14 PIK3C3 RUBCN	1.04e-06	5	165	3	29587298
Pubmed	ORF3a-Mediated Incomplete Autophagy Facilitates Severe Acute Respiratory Syndrome Coronavirus-2 Replication.	ATG14 PIK3C3 RUBCN	1.04e-06	5	165	3	34386498
Pubmed	A Large-scale genetic association study of esophageal adenocarcinoma risk.	FLT1 GRIK1 IFNGR2 LATS1 IGF2R PIK3C2A PIK3C3 CD48 MMP3 ASCC3 MBD4	1.04e-06	351	165	11	20453000
Pubmed	Dapper1 promotes autophagy by enhancing the Beclin1-Vps34-Atg14L complex formation.	ATG14 PIK3C3 RUBCN	2.08e-06	6	165	3	24980960
Pubmed	Regulation of Beclin 1 in autophagy.	ATG14 PIK3C3 RUBCN	2.08e-06	6	165	3	19372752
Pubmed	The RUN domain of rubicon is important for hVps34 binding, lipid kinase inhibition, and autophagy suppression.	ATG14 PIK3C3 RUBCN	2.08e-06	6	165	3	21062745
Pubmed	PtdIns(4,5)P2 signaling regulates ATG14 and autophagy.	ATG14 PIK3C3 RUBCN	2.08e-06	6	165	3	27621469
Pubmed	Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex.	ATG14 PIK3C3 RUBCN	3.62e-06	7	165	3	19270693
Pubmed	Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages.	ATG14 PIK3C3 RUBCN	3.62e-06	7	165	3	19270696
Pubmed	A fine-tuning mechanism underlying self-control for autophagy: deSUMOylation of BECN1 by SENP3.	ATG14 PIK3C3 RUBCN	3.62e-06	7	165	3	31373534
Pubmed	A kinase-independent role for EGF receptor in autophagy initiation.	ATG14 PIK3C3 RUBCN	5.77e-06	8	165	3	25594178
Pubmed	CUL3 (cullin 3)-mediated ubiquitination and degradation of BECN1 (beclin 1) inhibit autophagy and promote tumor progression.	ATG14 PIK3C3 RUBCN	5.77e-06	8	165	3	33977871
Pubmed	Grainyhead-like factor Get1/Grhl3 regulates formation of the epidermal leading edge during eyelid closure.	KRT6A KRT6B GRHL3	5.77e-06	8	165	3	18485343
Pubmed	Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy.	IGF2R AP2A1 AP2A2 PIK3C2A	6.73e-06	26	165	4	24067654
Pubmed	EGFR-mediated Beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance.	ATG14 PIK3C3 RUBCN	8.63e-06	9	165	3	24034250
Pubmed	Periderm Fate during Palatogenesis: TGF-β and Periderm Dedifferentiation.	KRT6A KRT6B GRHL3	8.63e-06	9	165	3	36751050
Pubmed	A gene expression map of human chromosome 21 orthologues in the mouse.	TSPEAR GRIK1 SCAF4 IFNGR2 PAXBP1 KCNE1 PRMT2	1.11e-05	158	165	7	12466855
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	GLIPR1 YPEL3 KDM4C SPTB GRIK1 TUBGCP5 LRP1B AP2A1 SACS HECTD2 SGSM2 NAV3 PRMT2 KDM4A METTL8 ZNF606 MBD4 MED13 LGI1	1.22e-05	1285	165	19	35914814
Pubmed	STYK1 promotes autophagy through enhancing the assembly of autophagy-specific class III phosphatidylinositol 3-kinase complex I.	ATG14 PIK3C3 RUBCN	1.23e-05	10	165	3	31696776
Pubmed	LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer's Disease.	ATG14 PIK3C3 RUBCN	1.23e-05	10	165	3	31257024
Pubmed	Receptor signaling lymphocyte-activation molecule family 1 (Slamf1) regulates membrane fusion and NADPH oxidase 2 (NOX2) activity by recruiting a Beclin-1/Vps34/ultraviolet radiation resistance-associated gene (UVRAG) complex.	ATG14 PIK3C3 RUBCN	1.23e-05	10	165	3	22493499
Pubmed	New consensus nomenclature for mammalian keratins.	KRT6A KRT6B KRT79 KRT75 KRT6C	1.27e-05	63	165	5	16831889
Pubmed	Functional analysis and identification of cis-regulatory elements of human chromosome 21 gene promoters.	TSPEAR GRIK1 PAXBP1 KCNE1	2.03e-05	34	165	4	20494980
Pubmed	Mutation analysis of large tumor suppressor genes LATS1 and LATS2 supports a tumor suppressor role in human cancer.	LATS1 LATS2	2.24e-05	2	165	2	25482410
Pubmed	Lats1/2-Mediated Alteration of Hippo Signaling Pathway Regulates the Fate of Bone Marrow-Derived Mesenchymal Stem Cells.	LATS1 LATS2	2.24e-05	2	165	2	30671453
Pubmed	Expression of UDP Glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells.	UGT2B15 UGT2B17	2.24e-05	2	165	2	32660355
Pubmed	Expression of MK6a dominant-negative and C-terminal mutant transgenes in mice has distinct phenotypic consequences in the epidermis and hair follicle.	KRT6A KRT6B	2.24e-05	2	165	2	10550543
Pubmed	The mouse keratin 6 isoforms are differentially expressed in the hair follicle, footpad, tongue and activated epidermis.	KRT6A KRT6B	2.24e-05	2	165	2	10550545
Pubmed	Teneurins assemble into presynaptic nanoclusters that promote synapse formation via postsynaptic non-teneurin ligands.	TENM4 TENM3	2.24e-05	2	165	2	35484136
Pubmed	A single copy of large tumor suppressor 1 or large tumor suppressor 2 is sufficient for normal hematopoiesis.	LATS1 LATS2	2.24e-05	2	165	2	32826458
Pubmed	AICAR Antiproliferative Properties Involve the AMPK-Independent Activation of the Tumor Suppressors LATS 1 and 2.	LATS1 LATS2	2.24e-05	2	165	2	29730476
Pubmed	The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence.	UGT2B15 UGT2B17	2.24e-05	2	165	2	1909870
Pubmed	The two functional keratin 6 genes of mouse are differentially regulated and evolved independently from their human orthologs.	KRT6A KRT6B	2.24e-05	2	165	2	9790766
Pubmed	Androgen glucuronidation: an unexpected target for androgen deprivation therapy, with prognosis and diagnostic implications.	UGT2B15 UGT2B17	2.24e-05	2	165	2	24121496
Pubmed	N-terminal truncation of Lats1 causes abnormal cell growth control and chromosomal instability.	LATS1 LATS2	2.24e-05	2	165	2	23230145
Pubmed	Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.	UGT2B15 UGT2B17	2.24e-05	2	165	2	24267955
Pubmed	Cloning of cDNAs encoding two related 100-kD coated vesicle proteins (alpha-adaptins).	AP2A1 AP2A2	2.24e-05	2	165	2	2564002
Pubmed	Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression.	UGT2B15 UGT2B17	2.24e-05	2	165	2	22170718
Pubmed	Discovery of a novel murine keratin 6 (K6) isoform explains the absence of hair and nail defects in mice deficient for K6a and K6b.	KRT6A KRT6B	2.24e-05	2	165	2	11489919
Pubmed	Introducing a null mutation in the mouse K6alpha and K6beta genes reveals their essential structural role in the oral mucosa.	KRT6A KRT6B	2.24e-05	2	165	2	10953016
Pubmed	The complete cDNA and deduced amino acid sequence of a type II mouse epidermal keratin of 60,000 Da: analysis of sequence differences between type I and type II keratins.	KRT6A KRT6B	2.24e-05	2	165	2	6207530
Pubmed	LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function.	LATS1 LATS2	2.24e-05	2	165	2	31848340
Pubmed	Localization of UDP glucuronosyltransferase gene(s) on mouse chromosome 5.	UGT2B15 UGT2B17	2.24e-05	2	165	2	3105095
Pubmed	UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells.	UGT2B15 UGT2B17	2.24e-05	2	165	2	17848572
Pubmed	Expression of LATS family proteins in ovarian tumors and its significance.	LATS1 LATS2	2.24e-05	2	165	2	25841306
Pubmed	Androgen and Estrogen Receptors in Breast Cancer Coregulate Human UDP-Glucuronosyltransferases 2B15 and 2B17.	UGT2B15 UGT2B17	2.24e-05	2	165	2	27496708
Pubmed	Evidence for a tumor suppressor role for the large tumor suppressor genes LATS1 and LATS2 in human cancer.	LATS1 LATS2	2.24e-05	2	165	2	24026096
Pubmed	KH-type splicing regulatory protein is a new component of chromatoid body.	PIWIL1 KHSRP	2.24e-05	2	165	2	28871057
Pubmed	The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.	UGT2B15 UGT2B17	2.24e-05	2	165	2	17698910
Pubmed	Mutagenic insertion and chromosome engineering resource (MICER).	LRP1B PGAP1	2.24e-05	2	165	2	15235602
Pubmed	Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer.	LATS1 LATS2	2.24e-05	2	165	2	32423384
Pubmed	Deletion of Lats1/2 in adult kidney epithelia leads to renal cell carcinoma.	LATS1 LATS2	2.24e-05	2	165	2	34060480
Pubmed	A reporter transgene based on a human keratin 6 gene promoter is specifically expressed in the periderm of mouse embryos.	KRT6A KRT6B	2.24e-05	2	165	2	11118885
Pubmed	Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.	LATS1 LATS2	2.24e-05	2	165	2	17049657
Pubmed	Lats1 and Lats2 are required for ovarian granulosa cell fate maintenance.	LATS1 LATS2	2.24e-05	2	165	2	31268774
Pubmed	The Hippo pathway regulates human megakaryocytic differentiation.	LATS1 LATS2	2.24e-05	2	165	2	27786336
Pubmed	Collapse of the keratin filament network through the expression of mutant keratin 6c observed in a case of focal plantar keratoderma.	KRT6A KRT6C	2.24e-05	2	165	2	23662636
Pubmed	Mouse UDP glucuronosyltransferase. cDNA and complete amino acid sequence and regulation.	UGT2B15 UGT2B17	2.24e-05	2	165	2	3117546
Pubmed	Cell type-dependent function of LATS1/2 in cancer cell growth.	LATS1 LATS2	2.24e-05	2	165	2	30531839
Pubmed	Delayed wound healing in keratin 6a knockout mice.	KRT6A KRT6B	2.24e-05	2	165	2	10866680
Pubmed	Structural investigations of the nickel-induced inhibition of truncated constructs of the JMJD2 family of histone demethylases using X-ray absorption spectroscopy.	KDM4C KDM4A	2.24e-05	2	165	2	23692052
Pubmed	Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.	LATS1 LATS2	2.24e-05	2	165	2	15746036
Pubmed	Cytokeratins mediate epithelial innate defense through their antimicrobial properties.	KRT6A KRT6B	2.24e-05	2	165	2	23006328
Pubmed	Identification of LATS transcriptional targets in HeLa cells using whole human genome oligonucleotide microarray.	LATS1 LATS2	2.24e-05	2	165	2	19799973
Pubmed	LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control.	LATS1 LATS2	2.24e-05	2	165	2	32015438
Pubmed	Cloning, physical mapping and structural characterization of the human alpha(A)-adaptin gene.	AP2A1 AP2A2	2.24e-05	2	165	2	12036598
Pubmed	A novel immuno-competitive capture mass spectrometry strategy for protein-protein interaction profiling reveals that LATS kinases regulate HCV replication through NS5A phosphorylation.	LATS1 LATS2	2.24e-05	2	165	2	25044019
Pubmed	Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation.	UGT2B15 UGT2B17	2.24e-05	2	165	2	28228532
Pubmed	Cellular specific expression of the androgen-conjugating enzymes UGT2B15 and UGT2B17 in the human prostate epithelium.	UGT2B15 UGT2B17	2.24e-05	2	165	2	15666817
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	KRT6A NUP107 RCN1 TFAM SCAF4 KHSRP BLMH BPTF RAB9A IGF2R AP2A1 KRT6C SACS SERPINB12 DKC1 ASCC3	3.22e-05	1024	165	16	24711643
Pubmed	Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.	LATS1 LATS2 ANAPC1	3.67e-05	14	165	3	29183995
Pubmed	Charting the molecular network of the drug target Bcr-Abl.	KRT6A KRT6B KRT79 KRT75 AP2A1 AP2A2 KRT6C SERPINB12	4.30e-05	266	165	8	19380743
Pubmed	LC3-Associated Phagocytosis in Myeloid Cells Promotes Tumor Immune Tolerance.	ATG14 PIK3C3 RUBCN	4.58e-05	15	165	3	30245008
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	KRT6A KRT79 KHSRP KRT75 PIK3C2A LRP6 ASCC3	5.38e-05	202	165	7	24639526
Pubmed	Hague (Hag). A new mouse hair mutation with an unstable semidominant allele.	KRT6A KRT6B KRT75	5.61e-05	16	165	3	12399393
Pubmed	The HSP90 family of genes in the human genome: insights into their divergence and evolution.	HSP90AB2P HSP90AA4P HSP90AB3P	5.61e-05	16	165	3	16269234
Pubmed	A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway.	LATS1 LATS2	6.69e-05	3	165	2	30308519
Pubmed	Clathrin-independent endocytic retrieval of SV proteins mediated by the clathrin adaptor AP-2 at mammalian central synapses.	AP2A1 AP2A2	6.69e-05	3	165	2	35014951
Pubmed	Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphism.	UGT2B15 UGT2B17	6.69e-05	3	165	2	19572376
Pubmed	A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2.	AP2A1 AP2A2	6.69e-05	3	165	2	18032517
Pubmed	Overcoming functional redundancy to elicit pachyonychia congenita-like nail lesions in transgenic mice.	KRT6A KRT6B	6.69e-05	3	165	2	15601842
Pubmed	Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis.	KRT6A KRT6B	6.69e-05	3	165	2	29587848
Pubmed	Analysis of imprinted gene expression and implantation in haploid androgenetic mouse embryos.	IGF2R ASB4	6.69e-05	3	165	2	24387305
Pubmed	Epigenetic regulation of steroid inactivating UDP-glucuronosyltransferases by microRNAs in prostate cancer.	UGT2B15 UGT2B17	6.69e-05	3	165	2	26385605
Pubmed	Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2.	LATS1 LATS2	6.69e-05	3	165	2	24012335
Pubmed	Comparative integromics on JMJD2A, JMJD2B and JMJD2C: preferential expression of JMJD2C in undifferentiated ES cells.	KDM4C KDM4A	6.69e-05	3	165	2	17611647
Pubmed	A small deletion hotspot in the type II keratin gene mK6irs1/Krt2-6g on mouse chromosome 15, a candidate for causing the wavy hair of the caracul (Ca) mutation.	KRT6A KRT6B	6.69e-05	3	165	2	14573483
Pubmed	LATS kinases and SLUG regulate the transition to advanced stage in aggressive oral cancer cells.	LATS1 LATS2	6.69e-05	3	165	2	35859006
Pubmed	PAQR3 controls autophagy by integrating AMPK signaling to enhance ATG14L-associated PI3K activity.	ATG14 PIK3C3	6.69e-05	3	165	2	26834238
Pubmed	AP2 adaptor complex mediates bile salt export pump internalization and modulates its hepatocanalicular expression and transport function.	AP2A1 AP2A2	6.69e-05	3	165	2	22262466
Pubmed	Envelope Glycoprotein Internalization Protects Human and Simian Immunodeficiency Virus-Infected Cells from Antibody-Dependent Cell-Mediated Cytotoxicity.	AP2A1 AP2A2	6.69e-05	3	165	2	26269175
Interaction	KRT84 interactions	KRT6A KRT6B USP37 KRT79 KRT75 KRT6C PRPH	1.23e-07	49	162	7	int:KRT84
Interaction	KRT26 interactions	KRT6A KRT6B KRT79 KRT75 KRT6C	8.43e-06	35	162	5	int:KRT26
Interaction	KRT25 interactions	KRT6A KRT6B KRT79 KRT75 KRT6C	8.43e-06	35	162	5	int:KRT25
Interaction	KRT20 interactions	KRT6A KRT6B KRT79 KRT75 KRT6C PRPH	1.14e-05	63	162	6	int:KRT20
Interaction	PHTF1 interactions	KRT6A KRT6B KRT75 KRT6C	1.76e-05	20	162	4	int:PHTF1
Interaction	CA2 interactions	KDM4C CCNF AP2A1 AP2A2 KCNMA1 DISP3	2.90e-05	74	162	6	int:CA2
Interaction	KRT12 interactions	KRT6A KRT6B KRT75 PRPH	3.77e-05	24	162	4	int:KRT12
Interaction	DNAJC7 interactions	POLE DNAJC18 CCNF TGFBR2 LATS2 SACS PIK3C2A WDR35 HSP90AB2P CACYBP ASCC3 HERC4 PLS3	4.11e-05	425	162	13	int:DNAJC7
Cytoband	12q13.13	KRT6A KRT6B KRT79 KRT6C	1.03e-04	67	165	4	12q13.13
GeneFamily	Keratins, type II	KRT6A KRT6B KRT79 KRT75 KRT6C	4.38e-07	27	105	5	609
GeneFamily	Zinc fingers C2H2-type\|PR/SET domain family	PRDM7 PRDM9 PRDM10	1.22e-04	17	105	3	1197
GeneFamily	Yippee like family	YPEL3 YPEL4	3.30e-04	5	105	2	1130
GeneFamily	Fibrinogen C domain containing\|Angiopoietin like	ANGPTL1 ANGPTL3	9.14e-04	8	105	2	905
GeneFamily	Phosphatidylinositol 3-kinase subunits	PIK3C2A PIK3C3	9.14e-04	8	105	2	831
GeneFamily	Low density lipoprotein receptors	LRP1B LRP6	2.50e-03	13	105	2	634
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	KLHL28 USP37 BPTF LATS1 IGF2R HOOK1 PIK3C2A SBF2 CEP97 MED13	2.60e-09	193	163	10	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	POLE PIWIL1 KRT79 TBC1D9 CCNF ANGPTL3 KLHDC4 KYNU	2.03e-07	168	163	8	a1755afa2cc50960ba60e07d84d61be429cdea72
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNKSR2 TEX11 NEB LRP1B TRANK1 TENM4 NAV3 DISP3	4.06e-07	184	163	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNKSR2 TEX11 NEB LRP1B TRANK1 TENM4 NAV3 DISP3	4.06e-07	184	163	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNKSR2 TEX11 NEB LRP1B TRANK1 TENM4 NAV3 DISP3	4.06e-07	184	163	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	DNAJC18 NEB ITK TRANK1 PIK3C3 PGAP1 METTL8	2.80e-06	167	163	7	c0c944eae0514dc8e00d0c2892a0792e157695ec
ToppCell	facs-Thymus-Flowthrough-3m-Myeloid\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ICOSLG SLCO5A1 PAXBP1 CEP120 PGAP1 GRHL3 KYNU	3.41e-06	172	163	7	356a66cd9303470e427005cc67fdd22a2c4bf971
ToppCell	facs-Thymus-Flowthrough-3m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ICOSLG SLCO5A1 PAXBP1 CEP120 PGAP1 GRHL3 KYNU	3.41e-06	172	163	7	46fadeee483fdf8402df92ec98575a09c6c15b16
ToppCell	facs-Thymus-Flowthrough-3m-Myeloid-macrophage\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ICOSLG SLCO5A1 PAXBP1 CEP120 PGAP1 GRHL3 KYNU	3.41e-06	172	163	7	438d2e7f1897668a14d85ca70722e5d0102606dc
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	STON1 SLC27A6 NCS1 RNF150 PTCHD1 KCNMA1 LGI1	5.12e-06	183	163	7	61a73de857f4ae02dcba3af348f436f602b28ff2
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRID2 ANGPTL1 VSTM4 RNF150 TENM4 TENM3 KCNMA1	6.78e-06	191	163	7	b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCell	Control-Control-Lymphocyte-T/NK-CD4+_T_activated\|Control / Disease, condition lineage and cell class	ASXL1 CDHR3 OAS3 ITK TRANK1 PGAP1 GNPDA2	8.57e-06	198	163	7	ee71543559836fd59adc0da877b2ca538cba60cb
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ICOSLG OMG TBC1D9 PTCHD1 KCNMA1 PLCXD3	2.22e-05	154	163	6	1e32969bee810adaf2d560f0824a16227df513d8
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STON1 KCNMA1 NAV3 PLCXD3 MMP3 GRHL3	2.57e-05	158	163	6	f296ca24fdedc33f1d24b79e7660763114ce7fa3
ToppCell	facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STON1 KCNMA1 NAV3 PLCXD3 MMP3 GRHL3	2.57e-05	158	163	6	8c7108f2c40d97a317762ba0b8eca76542b2ebaf
ToppCell	343B-Myeloid-Dendritic-cDC_activated\|343B / Donor, Lineage, Cell class and subclass (all cells)	ICOSLG IFNGR2 SLCO5A1 RAB9A CLEC4F RUBCN	3.75e-05	169	163	6	2098f15a388d019ed7f1d4c209affd5ca2886dcc
ToppCell	P07-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	NCAM1 GRID2 NEB CLCN1 TENM3 LGI1	4.13e-05	172	163	6	8d6a2a0d5f63b09a5a304a77e600a647f87e9de4
ToppCell	tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th\|T/NK_cells / Location, Cell class and cell subclass	DNAJC18 ANO10 NEB TRANK1 PIK3C3 PGAP1	4.27e-05	173	163	6	42c911ed16fabdabef063830e8407192d8bde950
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-11\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ICOSLG USP37 ANGPTL1 ZNF546 CCNF FSD1L	4.85e-05	177	163	6	3535575686c9700ab72700aae6f2070ebbb50044
ToppCell	droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 STON1 ZKSCAN7 WDR93 KLHL3 MBD4	5.16e-05	179	163	6	a09647750eba9d93c5efc1db3b555fefb5eec7b5
ToppCell	LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	TSPEAR RAD51AP2 FSD1L TENM4 HOOK1 LTA4H	5.16e-05	179	163	6	fd2cbee532e7b44113410dca82aec7db1a7fb69f
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SLC27A6 NCAM1 VSTM4 COLEC12 IGF2R PLS3	5.16e-05	179	163	6	b559f5a72cc9e3e35d05cb539b5c2e006e56e652
ToppCell	COVID-19-Epithelial-Ionocytes\|Epithelial / Condition, Lineage and Cell class	FLT1 NCAM1 GRIK1 VSTM4 RNF150 KCNMA1	5.49e-05	181	163	6	4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4
ToppCell	18-Distal-Epithelial-Multiciliated_cell\|Distal / Age, Tissue, Lineage and Cell class	CDHR3 OMG KCNE1 TEX26 UGT2B17 FBXO15	6.58e-05	187	163	6	8d7fa6b2950898e7f283401808378ba2a41b9651
ToppCell	TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6\|TCGA-Skin / Sample_Type by Project: Shred V9	KRT6A KRT6B KRT75 KRT6C SERPINB12 GRHL3	6.58e-05	187	163	6	2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NCAM1 GRID2 CNKSR2 TRANK1 NAV3 C1R	6.77e-05	188	163	6	ce85a56ac27a6432421dde93a1bafa8b943244b9
ToppCell	Club-club-5\|World / Class top	YPEL3 KRT6A KRT6B KHSRP IFNGR2 PLS3	6.77e-05	188	163	6	5911409108ececdb4f8112ec4bacc215e204001f
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	STON1 SLC27A6 GRID2 RNF150 KCNMA1 LGI1	6.77e-05	188	163	6	879de94924de978478696fc7838e05a4d795b905
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-myocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	STON1 SLC27A6 GRID2 RNF150 KCNMA1 LGI1	6.98e-05	189	163	6	ab7ece0a517499b70b7754720d3e434765363af6
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRID2 ANGPTL1 VSTM4 RNF150 TENM4 KCNMA1	6.98e-05	189	163	6	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	NCAM1 GRID2 CNKSR2 TRANK1 NAV3 C1R	7.18e-05	190	163	6	efb757f11c2809e66ddb48a5c84f5433f111cb7c
ToppCell	TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	KRT6A KRT6B KRT75 KRT6C MMP3 GRHL3	7.18e-05	190	163	6	3188c7bd225cbcf46a21e2fb784336cdd9665995
ToppCell	TCGA-Skin-Primary_Tumor\|TCGA-Skin / Sample_Type by Project: Shred V9	KRT6A KRT6B KRT75 KRT6C MMP3 GRHL3	7.18e-05	190	163	6	e2b26a03c6ab24d9b0f4150c47597be37767d86e
ToppCell	TCGA-Skin-Primary_Tumor-Melanoma\|TCGA-Skin / Sample_Type by Project: Shred V9	KRT6A KRT6B KRT75 KRT6C MMP3 GRHL3	7.18e-05	190	163	6	01fb45add4661bc86cd0a34fac35177907152dbb
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GRID2 VSTM4 COLEC12 RNF150 TENM4 KCNMA1	7.39e-05	191	163	6	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	Entopeduncular-Neuronal\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	RASGEF1A YPEL4 PTCHD1 TRANK1 HOOK1 SLC2A13	7.61e-05	192	163	6	4c35e5c28a40b439044797ba1f06cb7c36b2a8de
ToppCell	E15.5-Mesenchymal\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	RCN1 NCAM1 VSTM4 COLEC12 IGF2R PLS3	7.83e-05	193	163	6	22a9f5b61f197757f72840b9cb849cdb20430e72
ToppCell	COPD-Myeloid\|COPD / Disease state, Lineage and Cell class	IFNGR2 SBF2 KCNMA1 LTA4H DENND5A KYNU	7.83e-05	193	163	6	f58552e286aa27e592497ad78776f58f8ee09841
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 DNAJC18 TGFBR2 PIK3C2A ST6GALNAC3 NAV3	8.06e-05	194	163	6	74a9fdb73f279bebb6337510deab9aaaf9f7e957
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SLC27A6 RCN1 NCAM1 VSTM4 COLEC12 PLS3	8.06e-05	194	163	6	f2f7b9aad7588c8020a4850ff9333e1db8eafac7
ToppCell	COVID-19-Myeloid-Monocyte-derived_macrophages\|COVID-19 / group, cell type (main and fine annotations)	COLEC12 AP2A2 KCNE1 SBF2 KCNMA1 KYNU	8.29e-05	195	163	6	c172c5599379c29123340621a36bfb1fc90c2115
ToppCell	facs-Brain_Non-Myeloid-Cortex-3m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RASGEF1A CNKSR2 TRANK1 TENM4 KCTD16 SLC2A13	8.29e-05	195	163	6	ffbab350e67d9c4b66c0ab84550daec8b8139a27
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEB USP37 ANGPTL1 COLEC12 KCNMA1 ASCC3	8.29e-05	195	163	6	5c86fddd6d0530beecf45ea5ba6b823123847696
ToppCell	Bronchial-NucSeq-Stromal-Mesofibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SPTB ACSM1 NEB RNF150 TENM3 FBXO15	8.52e-05	196	163	6	96e5c6d155273e82ebafa180df8bb589c3e3e54e
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SLC27A6 RCN1 NCAM1 VSTM4 COLEC12 TENM4	8.52e-05	196	163	6	028a06ed92f1c058dcbeacd335625bf529e87a7b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 DNAJC18 TGFBR2 PIK3C2A ST6GALNAC3 NAV3	8.52e-05	196	163	6	22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCell	Bronchial-NucSeq-Stromal-Mesofibroblastic-Mesothelia\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SPTB ACSM1 NEB RNF150 TENM3 FBXO15	8.52e-05	196	163	6	ce13af36fc2932e8125013041742593ff3d07e86
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 DNAJC18 TGFBR2 PIK3C2A ST6GALNAC3 NAV3	8.52e-05	196	163	6	adee900dcd16dbaba15c58bdcace09ba20214950
ToppCell	10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	RCN1 NCAM1 COLEC12 TENM4 TENM3 PLS3	8.76e-05	197	163	6	2ca5ebb708935a90b12b8e98a22ae2d664ed002e
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CNKSR2 LRP1B KLHL3 COLEC12 HECTD2 SBF2	8.76e-05	197	163	6	0034bae02ee7fcfea520d453ca3c842ab6963b12
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANGPTL1 COLEC12 TENM3 KCNMA1 PLCXD3 MMP3	8.76e-05	197	163	6	cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COLEC12 RNF150 AP2A2 KCNE1 KCNMA1 KYNU	9.01e-05	198	163	6	c7dbf24caae5c4ef285845d13055de9e07281bb3
ToppCell	10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	STON1 NCAM1 VSTM4 COLEC12 TENM4 PLS3	9.01e-05	198	163	6	bc9c9f2c87282b5ef8514773e065d2a6b5dde338
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	GRID2 GRIK1 RNF150 SLC44A5 KCTD16 SLC2A13	9.52e-05	200	163	6	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	GRID2 GRIK1 RNF150 SLC44A5 KCTD16 SLC2A13	9.52e-05	200	163	6	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	GRID2 GRIK1 RNF150 SLC44A5 KCTD16 SLC2A13	9.52e-05	200	163	6	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	GRID2 GRIK1 RNF150 SLC44A5 KCTD16 SLC2A13	9.52e-05	200	163	6	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	GRID2 GRIK1 RNF150 SLC44A5 KCTD16 SLC2A13	9.52e-05	200	163	6	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Sepsis-ICU-NoSEP-Lymphocyte-T/NK-NK_CD56bright\|ICU-NoSEP / Disease, condition lineage and cell class	NUP107 KDM4C CDHR3 RASGEF1A NCAM1 TUBGCP5	9.52e-05	200	163	6	c2df917900872453ea17a39928e39d071a6d3339
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	GRID2 GRIK1 RNF150 SLC44A5 KCTD16 SLC2A13	9.52e-05	200	163	6	961858738ce35db8760c8c2e136f8369bc444ccf
Drug	SC-791	KRT6A KRT6B KRT75 KRT6C	3.66e-08	6	162	4	CID010291510
Drug	dithranol	KRT6A KRT6B KRT75 KRT6C LTA4H	1.36e-07	18	162	5	CID000002202
Drug	Bhg-(2-1)fuc	KRT6A KRT6B BLMH KRT75 KRT6C	8.12e-07	25	162	5	CID005287784
Drug	AGN 193109	KRT6A KRT6B KRT75 KRT6C MMP3	2.51e-06	31	162	5	CID000177238
Drug	clobestasol propionate	KRT6A KRT6B KRT75 KRT6C	5.47e-06	17	162	4	CID000002791
Drug	chrysarobin	KRT6A KRT6B FLT1 KRT75 KRT6C	6.22e-06	37	162	5	CID000068111
Drug	Olux	KRT6A KRT6B KRT75 KRT6C	1.09e-05	20	162	4	CID000032797
Drug	butirosin A from Bacillus vitellinus; Up 200; 10uM; PC3; HG-U133A	SPTB PPWD1 NCS1 BLMH CACTIN CLN5 KCNMA1 DKC1 KYNU	1.38e-05	200	162	9	666_UP
Drug	MK-6	KRT6A KRT6B KRT75 KRT6C	2.35e-05	24	162	4	CID005283547
Drug	plakin	KRT6A KRT6B SPTB KRT75 KRT6C PLS3	2.65e-05	82	162	6	CID000018752
Disease	kidney cancer (implicated_via_orthology)	POLE LATS1 LATS2	2.50e-05	11	160	3	DOID:263 (implicated_via_orthology)
Disease	level of protocadherin-12 in blood serum	C1RL C1R	2.92e-05	2	160	2	OBA_2042780
Disease	diacylglycerol kinase beta measurement	C1RL C1R	8.73e-05	3	160	2	EFO_0801525
Disease	cholic acid glucuronide measurement	UGT2B15 UGT2B17	8.73e-05	3	160	2	EFO_0800574
Disease	Uterine leiomyoma	STON1 NUP107 NCAM1 TEX11 KCNMA1	1.41e-04	91	160	5	HP_0000131
Disease	Pachyonychia congenita syndrome	KRT6A KRT6B	1.74e-04	4	160	2	cv:C0265334
Disease	X-25937 measurement	UGT2B15 UGT2B17	1.74e-04	4	160	2	EFO_0800937
Disease	Pachyonychia Congenita, Jadassohn Lewandowsky Type	KRT6A KRT6B	1.74e-04	4	160	2	C1706595
Disease	pachyonychia congenita (is_implicated_in)	KRT6A KRT6B	1.74e-04	4	160	2	DOID:0050449 (is_implicated_in)
Disease	Pachyonychia Congenita, Type 2 (disorder)	KRT6A KRT6B	1.74e-04	4	160	2	C1721007
Disease	prolyl 4-hydroxylase subunit alpha-2 measurement	C1RL C1R	1.74e-04	4	160	2	EFO_0802918
Disease	Pachyonychia Congenita	KRT6A KRT6B	2.89e-04	5	160	2	C0265334
Disease	Cerebral Astrocytoma	LATS1 LATS2 MMP3	3.30e-04	25	160	3	C0750935
Disease	Intracranial Astrocytoma	LATS1 LATS2 MMP3	3.30e-04	25	160	3	C0750936
Disease	Astrocytoma	LATS1 LATS2 MMP3	3.30e-04	25	160	3	C0004114
Disease	Grade I Astrocytoma	LATS1 LATS2 MMP3	3.30e-04	25	160	3	C1704230
Disease	Subependymal Giant Cell Astrocytoma	LATS1 LATS2 MMP3	3.30e-04	25	160	3	C0205768
Disease	Mixed oligoastrocytoma	LATS1 LATS2 MMP3	3.30e-04	25	160	3	C0547065
Disease	Pilocytic Astrocytoma	LATS1 LATS2 MMP3	3.30e-04	25	160	3	C0334583
Disease	Juvenile Pilocytic Astrocytoma	LATS1 LATS2 MMP3	3.30e-04	25	160	3	C0280783
Disease	Diffuse Astrocytoma	LATS1 LATS2 MMP3	3.30e-04	25	160	3	C0280785
Disease	Childhood Cerebral Astrocytoma	LATS1 LATS2 MMP3	3.30e-04	25	160	3	C0338070
Disease	Gemistocytic astrocytoma	LATS1 LATS2 MMP3	3.71e-04	26	160	3	C0334581
Disease	Protoplasmic astrocytoma	LATS1 LATS2 MMP3	3.71e-04	26	160	3	C0334580
Disease	Fibrillary Astrocytoma	LATS1 LATS2 MMP3	3.71e-04	26	160	3	C0334582
Disease	energy expenditure	KDM4C CDHR3 COLEC12	4.16e-04	27	160	3	EFO_0005109
Disease	Anaplastic astrocytoma	LATS1 LATS2 MMP3	4.16e-04	27	160	3	C0334579
Disease	Drug habituation	PIWIL1 COLEC12 SLC2A13 ZNF606 TMPRSS7	4.18e-04	115	160	5	C0013170
Disease	Drug abuse	PIWIL1 COLEC12 SLC2A13 ZNF606 TMPRSS7	4.18e-04	115	160	5	C0013146
Disease	Prescription Drug Abuse	PIWIL1 COLEC12 SLC2A13 ZNF606 TMPRSS7	4.18e-04	115	160	5	C4316881
Disease	Substance-Related Disorders	PIWIL1 COLEC12 SLC2A13 ZNF606 TMPRSS7	4.18e-04	115	160	5	C0236969
Disease	Drug Use Disorders	PIWIL1 COLEC12 SLC2A13 ZNF606 TMPRSS7	4.18e-04	115	160	5	C0013222
Disease	Drug Dependence	PIWIL1 COLEC12 SLC2A13 ZNF606 TMPRSS7	4.18e-04	115	160	5	C1510472
Disease	Substance Dependence	PIWIL1 COLEC12 SLC2A13 ZNF606 TMPRSS7	4.18e-04	115	160	5	C0038580
Disease	Substance Use Disorders	PIWIL1 COLEC12 SLC2A13 ZNF606 TMPRSS7	4.18e-04	115	160	5	C0038586
Disease	Organic Mental Disorders, Substance-Induced	PIWIL1 COLEC12 SLC2A13 ZNF606 TMPRSS7	4.18e-04	115	160	5	C0029231
Disease	dynactin subunit 2 measurement	C1RL C1R	4.32e-04	6	160	2	EFO_0020338
Disease	complement component 1 q subcomponent-binding protein, mitochondrial measurement	C1RL C1R	4.32e-04	6	160	2	EFO_0020280
Disease	Substance abuse problem	PIWIL1 COLEC12 SLC2A13 ZNF606 TMPRSS7	4.35e-04	116	160	5	C0740858
Disease	clusterin measurement	C1RL C1R	6.03e-04	7	160	2	EFO_0007655
Disease	complement C1r subcomponent measurement	C1RL C1R	6.03e-04	7	160	2	EFO_0008090
Disease	X-24574 measurement	UGT2B15 UGT2B17	6.03e-04	7	160	2	EFO_0800897
Disease	r-spondin-3 measurement	C1RL C1R	6.03e-04	7	160	2	EFO_0021878
Disease	cancer (implicated_via_orthology)	FLT1 POLE LATS1 LATS2 HSP90AB2P HSP90AA4P HSP90AB3P	6.76e-04	268	160	7	DOID:162 (implicated_via_orthology)
Disease	deoxycholic acid glucuronide measurement	UGT2B15 UGT2B17	8.01e-04	8	160	2	EFO_0800575
Disease	benign neoplasm (implicated_via_orthology)	LATS1 LATS2	8.01e-04	8	160	2	DOID:0060072 (implicated_via_orthology)
Disease	cis-4-decenoylcarnitine (C10:1) measurement	SLC44A5 ST6GALNAC3	8.01e-04	8	160	2	EFO_0800311
Disease	Spinocerebellar Ataxia Type 2	GRID2 ANO10 RUBCN	8.28e-04	34	160	3	C0752121
Disease	Spinocerebellar Ataxia Type 1	GRID2 ANO10 RUBCN	8.28e-04	34	160	3	C0752120
Disease	Spinocerebellar Ataxia Type 5	GRID2 ANO10 RUBCN	8.28e-04	34	160	3	C0752123
Disease	Spinocerebellar Ataxia Type 7	GRID2 ANO10 RUBCN	8.28e-04	34	160	3	C0752125
Disease	Spinocerebellar Ataxia Type 6 (disorder)	GRID2 ANO10 RUBCN	8.28e-04	34	160	3	C0752124
Disease	Ataxia, Spinocerebellar	GRID2 ANO10 RUBCN	8.28e-04	34	160	3	C0087012
Disease	Spinocerebellar Ataxia Type 4	GRID2 ANO10 RUBCN	9.02e-04	35	160	3	C0752122
Disease	tyrosine-protein phosphatase non-receptor type 4 measurement	C1RL C1R	1.03e-03	9	160	2	EFO_0802172
Disease	Liver Cirrhosis, Experimental	GLIPR1 YPEL3 RCN1 TBC1D9 TGFBR2 COLEC12 CLEC4F IGF2R ANGPTL3 CD48 LTA4H KYNU	1.10e-03	774	160	12	C0023893
Disease	tooth agenesis (is_implicated_in)	TSPEAR LRP6	1.28e-03	10	160	2	DOID:0050591 (is_implicated_in)
Disease	4-androsten-3alpha,17alpha-diol monosulfate (3) measurement	UGT2B15 UGT2B17	1.28e-03	10	160	2	EFO_0022090
Disease	alopecia areata (is_marker_for)	KDM4C KDM4A	1.28e-03	10	160	2	DOID:986 (is_marker_for)
Disease	adseverin measurement	C1RL C1R	1.28e-03	10	160	2	EFO_0801358
Disease	f-box/LRR-repeat protein 4 measurement	C1RL C1R	1.28e-03	10	160	2	EFO_0802538
Disease	DNA repair protein RAD51 homolog 4 measurement	UGT2B15 UGT2B17	1.56e-03	11	160	2	EFO_0801531
Disease	microfibrillar-associated protein 2 measurement	C1RL C1R	1.56e-03	11	160	2	EFO_0801801
Disease	myocardial infarction (biomarker_via_orthology)	FLT1 SLC27A6 NCAM1 TGFBR2 CACYBP	1.84e-03	160	160	5	DOID:5844 (biomarker_via_orthology)
Disease	mismatch repair cancer syndrome (is_implicated_in)	POLE TGFBR2	1.86e-03	12	160	2	DOID:0112182 (is_implicated_in)
Disease	decanoylcarnitine measurement	SLC44A5 ST6GALNAC3	1.86e-03	12	160	2	EFO_0021039
Disease	5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement	UGT2B15 UGT2B17	1.86e-03	12	160	2	EFO_0800291
Disease	epilepsy (implicated_via_orthology)	LRP1B NDEL1 SBF2 KCNMA1 LGI1	2.00e-03	163	160	5	DOID:1826 (implicated_via_orthology)
Disease	Short Rib-Polydactyly Syndrome	CEP120 WDR35	2.19e-03	13	160	2	C0036996
Disease	androstenediol (3alpha, 17alpha) monosulfate (3) measurement	UGT2B15 UGT2B17	2.19e-03	13	160	2	EFO_0800293
Disease	X-19141 measurement	UGT2B15 UGT2B17	2.19e-03	13	160	2	EFO_0800799
Disease	COVID-19, mortality	KDM4C NCAM1 LRP1B TENM3 KCNMA1	2.39e-03	170	160	5	EFO_0004352, MONDO_0100096
Disease	pulmonary fibrosis (biomarker_via_orthology)	TGFBR2 HSP90AB2P HSP90AB3P	2.54e-03	50	160	3	DOID:3770 (biomarker_via_orthology)
Disease	atrial fibrillation (is_implicated_in)	KCNE1 MMP3	2.55e-03	14	160	2	DOID:0060224 (is_implicated_in)
Disease	Saldino-Noonan Syndrome	CEP120 WDR35	2.55e-03	14	160	2	C0036069
Disease	Majewski Syndrome	CEP120 WDR35	2.55e-03	14	160	2	C0024507
Disease	5alpha-androstan-3alpha,17alpha-diol monosulfate measurement	UGT2B15 UGT2B17	2.55e-03	14	160	2	EFO_0800283
Disease	lower face morphology measurement	SLC27A6 LRP1B ANAPC1 NAV3	2.98e-03	109	160	4	EFO_0010948
Disease	interleukin 12 measurement	GRID2 TENM4 SACS	3.00e-03	53	160	3	EFO_0004753
Disease	Cannabis use	NCAM1 AP2A2	3.34e-03	16	160	2	EFO_0007585
Disease	response to citalopram, antidepressant-induced dizziness, response to buspirone, response to antidepressant	NTMT1 HSP90AB2P	3.77e-03	17	160	2	EFO_0006321, EFO_0006329, EFO_0006330, GO_0036276
Disease	Abnormality of refraction	FLT1 GRIK1 CNKSR2 TFAM RNF150 PTCHD1 LATS2 GNPDA2 KCNMA1 PLCXD3	3.82e-03	673	160	10	HP_0000539
Disease	adverse effect, response to xenobiotic stimulus	STON1 LRP1B SCAF4	4.07e-03	59	160	3	EFO_0009658, GO_0009410
Disease	Child Behaviour Checklist assessment	TENM4 TENM3	4.22e-03	18	160	2	EFO_0005661
Disease	5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement	UGT2B15 UGT2B17	4.22e-03	18	160	2	EFO_0800288
Disease	etiocholanolone glucuronide measurement	UGT2B15 UGT2B17	4.70e-03	19	160	2	EFO_0800362
Disease	carcinoma (implicated_via_orthology)	FLT1 LATS1 LATS2	5.12e-03	64	160	3	DOID:305 (implicated_via_orthology)
Disease	diet measurement, body mass index	GRID2 LGI1	5.21e-03	20	160	2	EFO_0004340, EFO_0008111
Disease	androsterone glucuronide measurement	UGT2B15 UGT2B17	5.21e-03	20	160	2	EFO_0800317
Disease	Sarcomatoid Renal Cell Carcinoma	FLT1 LRP1B KCNMA1 NAV3	5.28e-03	128	160	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	FLT1 LRP1B KCNMA1 NAV3	5.28e-03	128	160	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	FLT1 LRP1B KCNMA1 NAV3	5.28e-03	128	160	4	C1266044
Disease	Papillary Renal Cell Carcinoma	FLT1 LRP1B KCNMA1 NAV3	5.28e-03	128	160	4	C1306837
Disease	Renal Cell Carcinoma	FLT1 LRP1B KCNMA1 NAV3	5.28e-03	128	160	4	C0007134

Protein segments in the cluster

Peptide	Gene	Start	Entry
KDYRSKVLFWDNAYE	PRMT2	256	P55345
WKFDFSFYVATKEQQ	DISP3	916	Q9P2K9
YSAYYSWVEEKKTTQ	ATG14	276	Q6ZNE5
AYWALRFKEQEYSTE	ASB4	216	Q9Y574
LYYNWKTVTVVYEDS	GRIK1	166	P39086
LAEKYAVDYSWYVDT	AP2A1	431	O95782
LEDWSDKKVYAEYSS	ANGPTL1	371	O95841
EDWKDNKHYIEYSFY	ANGPTL3	336	Q9Y5C1
NSWKTTLSVDDYFKY	CCDC87	586	Q9NVE4
EDTENENEKKIWYYS	BPTF	481	Q12830
FYTKVLNYVDWIKKE	C1R	686	P00736
KVEQWKEKFFEDYYG	ASXL1	346	Q8IXJ9
LSEKEYWEEYKNVGS	CCDC83	131	Q8IWF9
KVAILAEKYAVDYTW	AP2A2	426	O94973
AEKYAVDYTWYVDTI	AP2A2	431	O94973
KEAYVRDFTNIYWSQ	RAD51AP2	286	Q09MP3
KDDKISWEEYKQATY	RCN1	131	Q15293
QNLSNWKKEFIYYAD	RAB9A	96	P51151
DNIEFYAKSVYWENT	NUP107	286	P57740
YVEKFSYKSITTDDW	LTA4H	411	P09960
SYKSITTDDWKDFLY	LTA4H	416	P09960
TTDDWKDFLYSYFKD	LTA4H	421	P09960
KLEDTWYTRFALKYQ	ANO10	181	Q9NW15
VWEDYDKYVIFASFN	ANO10	236	Q9NW15
VTYKGTQWYEQTKEE	ANAPC1	1636	Q9H1A4
EAESWYQTKYEELQV	KRT6C	351	P48668
NWYDEIQDYDFKTRI	GLIPR1	116	P48060
TLFEDYIYWTDGKTK	LRP1B	3221	Q9NZR2
IKAFLIWAYFDKEFS	MAIP1	126	Q8WWC4
FIKIEEDTWQKYYLE	KCNMA1	581	Q12791
YFTEKEVQQWYKGFI	NCS1	21	P62166
QYTDDKIWSSYTEYV	KCTD16	261	Q68DU8
EAESWYQTKYEELQV	KRT6A	351	P02538
DNEWVVRLYYSFQDK	LATS1	761	O95835
AEADNEWVVKLYYSF	LATS2	721	Q9NRM7
EWVVKLYYSFQDKDS	LATS2	726	Q9NRM7
VSYVKEYWNDVFSDF	TRMU	71	O75648
NVNVSSLKKWDYYIE	SBF2	1571	Q86WG5
SLKKWDYYIEETLST	SBF2	1576	Q86WG5
YWEVKAQKDCKSYSV	FSD1L	386	Q9BXM9
EEYGEFYKSLTNDWK	HSP90AB2P	221	Q58FF8
KEYGEFYKSLTSDWE	HSP90AB3P	241	Q58FF7
AEAEAWYQTKYEELQ	KRT79	331	Q5XKE5
YAKTDLTIKYFWDVV	HECTD2	681	Q5U5R9
EKNKTYFFVEDKYWR	MMP3	396	P08254
EENTWFSYLKKGYLT	CANT1	121	Q8WVQ1
TEYAWQKFIIFYDSE	GRID2	161	O43424
YSEEEKYAFVNWINK	PLS3	121	P13797
EAESWYQTKYEELQI	KRT6B	351	P04259
TYKNFFYLIKWDELI	PIK3C2A	731	O00443
QEAEEWYKSKYADLS	PRPH	281	P41219
SKNYQDKKSWVEYLS	PDE6B	686	P35913
EKEDSKIYTDWANHY	NAV3	76	Q8IVL0
WKNFTDKCYYFSVEK	COLEC12	611	Q5KU26
SNYGWDQSDKFVKIY	CACYBP	76	Q9HB71
ELEKNTEYKGEYWAE	HERC4	951	Q5GLZ8
IAWSVYEFFKYLITK	SLC25A28	341	Q96A46
YEFFKYLITKRQEEW	SLC25A28	346	Q96A46
YSEFEELERKYWKNL	KDM4A	111	O75164
YEDLERKYWKNLTFV	KDM4C	116	Q9H3R0
YEEQKLYWADAKLNF	LRP6	191	O75581
KAYSWTEKLILSENY	LRRC37B	576	Q96QE4
WALYKYFISFKEELA	TUBGCP5	366	Q96RT8
VAKVADYWLDVLYSK	POLE	1006	Q07864
LKVWYAASYAEFVNQ	PRDM10	321	Q9NQV6
DCIKSQFEAWRSKYY	PAXBP1	596	Q9Y5B6
LFLYTKVEDYSKWIT	PRSS54	251	Q6PEW0
DLNDVYVYWQTSESK	ICOSLG	46	O75144
DAFKDISIYFTKEEW	PRDM9	26	Q9NQV7
YTKDYTEGWVEFRDK	ABT1	101	Q9ULW3
QKFSYTSEDEAWKTY	GRHL3	21	Q8TE85
ETVFYALESWIKYDV	KLHL28	196	Q9NXS3
EAVWLTDNTYKYEDL	CCNF	376	P41002
WYQLLSNKYTKFKSE	CEP120	111	Q8N960
VQDKEAGYWKKEYIT	FBXO15	146	Q8NCQ5
YVISQKESLKAEWLY	CEP97	236	Q8IW35
DKIWDYKLLVYVTDD	CDHR3	641	Q6ZTQ4
DWQEIIALYEKDNTY	CDK5RAP3	96	Q96JB5
YDFYTKVLSYVDWIK	C1RL	466	Q9NZP8
IWDFLEKAQTYYETL	DENND5A	1166	Q6IQ26
FTWEYRDKDKNYQKI	BLMH	231	Q13867
IVKFSDEYLTKQWKY	MBD4	516	O95243
LDNYDLASEWAAKYI	GNPDA2	6	Q8TDQ7
TEYVKGDNRKFEIWY	MCF2	766	P10911
VVYQVQFKYTDSKWF	IFNGR2	61	P38484
KDYIDYIQTSCWKEK	DNAJC18	301	Q9H819
ELYVYNTRKDTWTKV	KLHDC4	96	Q8TBB5
VEAYSYKTNEWFFVA	KLHL3	411	Q9UH77
YIESDAWQEKDKAYV	KCNE1	81	P15382
YYSWEKAFKTSFKLS	KRBOX4	146	Q5JUW0
YEDIAFKIVNREWEY	CACTIN	716	Q8WUQ7
TKDKSYWEDYRQFCK	SLC44A5	136	Q8NCS7
VAYTSYEKNKWNETI	ERMARD	631	Q5T6L9
KFRDYEEKLIVSAWY	HOOK1	656	Q9UJC3
FYKSLTINWEDYLAV	HSP90AA4P	116	Q58FG1
ENYKQLTWFYTFDQK	CD48	51	P09326
TWKQEYVDYSESAKK	DKC1	411	O60832
WDFSKYYVSNFSKDL	RUBCN	766	Q92622
KADYKQYWDVELGVT	SCAF4	586	O95104
VVDWYSSKTFSDEDY	SACS	1231	Q9NZJ4
EEQVKYEREASKYWD	METTL8	76	Q9H825
KEWVGYDNAISFSYK	OVGP1	326	Q12889
YWTINYNAKDKTVGD	OAS3	1011	Q9Y6K5
TYEWYNKSISRDKAE	ITK	236	Q08881
KEEWYTAFVNITYAE	RNF150	36	Q9ULK6
IEDEKQFYSKAKTYW	NTMT1	6	Q9BV86
ETKFKTEDIFWAYNF	SLC2A13	486	Q96QE2
KYNNKTYRVDDIDWD	PIWIL1	311	Q96J94
KAWEEYYKKQAQVAT	KHSRP	646	Q92945
YTWEAVDTKNNVLYK	IGF2R	51	P11717
YFFTWDTEYACVKEK	IGF2R	456	P11717
KVYNYVDWIKDTIAA	PRSS3P2	231	Q8NHM4
YWNTSVQEDVLEYTK	PTCHD1	566	Q96NR3
VESEVSQKSLWNYDY	TAF1L	301	Q8IZX4
EEQDLVWKFRYYLTN	PIK3C3	311	Q8NEB9
KNVNWEYKTDTDLYE	PPWD1	261	Q96BP3
DAFKDISIYFTKEEW	PRDM7	26	Q9NQW5
SELEKSVYWDYALVV	SGSM2	306	O43147
IFIFLAWYSIKYKED	SLCO5A1	751	Q9H2Y9
DKWAAELSELYSYTE	STRIP1	76	Q5VSL9
DYFFKEANTTIYVIW	ST6GALNAC3	141	Q8NDV1
YEEYASWKTEKDIFS	TGFBR2	281	P37173
KWTYVAYNESEKIYF	PGAP1	356	Q75T13
LEEDEANIAWKYYKF	MED13	606	Q9UHV7
DAYRAEWQVYKEEIS	TFAM	101	Q00059
YSLDQDKWASVFYTV	OR5AR1	266	Q8NGP9
KSDTAYQWNLKYLDV	OMG	116	P23515
VLVNAVYFKAKWETY	SERPINB12	186	Q96P63
VYFKAKWETYFDHEN	SERPINB12	191	Q96P63
FASYVLDYWAQKEKE	ACSM1	51	Q08AH1
SKQDALDYITWTYFF	ASCC3	1746	Q8N3C0
AKWVKQDNETGIYYE	CLN5	196	O75503
YYFSSVKKSWHEAEQ	CLEC4F	481	Q8N1N0
DYVSAKSLQAYKWSY	CLCN1	136	P35523
FVLKDASLYWYINEE	CNKSR2	596	Q8WXI2
LKSLDWNAEYEVYVV	NCAM1	671	P13591
AQEVSLKYLWEKDYQ	PLCXD3	176	Q63HM9
DLTKTYSLEAYDNWF	RASGEF1A	256	Q8N9B8
SAKYESAYQAVVWKI	STON1	621	Q9Y6Q2
DLLAYWNDTYKFISK	SSH2	366	Q76I76
WLYISKTESKDAFYF	TMPRSS7	96	Q7RTY8
KSYDYEAWAKLDVDR	RPAP3	86	Q9H6T3
EEEKLVNYYSCSYWK	TBC1D9	156	Q6ZT07
TRNWFTDLEYKYITK	ZNF546	126	Q86UE3
YEVTNFRSLLWYKQE	TRAV36DV7	46	A0A075B6V5
DLSYYFIWDKTDVYN	TENM4	1111	Q6N022
LDWDDTKYYDKALNA	TEX11	276	Q8IYF3
AYTFIWDKTDAYNQK	TENM3	1056	Q9P273
WDKTDAYNQKVYGLS	TENM3	1061	Q9P273
ISDTQKDWKFFESFY	PPP1R36	226	Q96LQ0
SWIKEKEQIYSSLDY	SPTB	651	P11277
KVYNYVDWIKDTIAA	PRSS2	231	P07478
WSEDSYYEALAKAQK	SAP30BP	191	Q9UHR5
LKDFYDIYEVAALKW	TPCN1	396	Q9ULQ1
WKYEQAFETSQKYKE	YPEL4	96	Q96NS1
VYDIKKQAWFTYNDL	USP37	911	Q86T82
WEQQAEIFNASYKKY	WDR93	326	Q6P2C0
EIFNASYKKYLDREW	WDR93	331	Q6P2C0
VAYEDLSVDYTQKKW	ZKSCAN7	231	Q9P0L1
SAVYKWTEEKFVSYQ	TSPEAR	351	Q8WU66
KTKETWAFFEDLYVY	VSTM4	166	Q8IW00
YKFEECDKAFYWVLS	ZNF355P	156	Q9NSJ1
QYSDEYTWKSHSKED	TEX26	71	Q8N6G2
QIYDLKKWDQFYSEV	UGT2B15	226	P54855
LLYNFFTDSEAYKEW	TRANK1	1576	O15050
FWSDCKKYDVTVFQY	SLC27A6	296	Q9Y2P4
IFDKIYSTKSDVWSY	FLT1	1071	P17948
YCVVFWDTKNNEKYV	WDR35	356	Q9P2L0
QAYDLKKWDQFYSEV	UGT2B17	226	O75795
GTVEKAYKYNEWEKV	ZNF606	366	Q8WXB4
LGWKYEQAFESSQKY	YPEL3	86	P61236
AEAESWYQTKYEELQ	KRT75	336	O95678
YLEEELDKWAKIAAY	KYNU	86	Q16719
YSFTQVYNWDAEKAK	LGI1	496	O95970
TAYWKELSLKYKQSF	NDEL1	16	Q9GZM8
YNLSDNVYKQDWEKS	NEB	801	P20929
ALQSDVEYKADYNSW	NEB	941	P20929